In this edition, ultra-processed grains linked to elevated risk for IBD, CTA use for GI bleeds increase and more.
Read the full coverage here:
Ultra-processed grains linked to elevated risk for IBD, especially ulcerative colitis
'Double whammy:' CTA use for GI bleeds rise, but diagnostic yield drops
'Another layer of benefit': GLP-1s linked to lower risk for peptic ulcer disease
'Simplified care models' needed for chronic HBV care to meet 2030 global elimination goals
'Stay vigilant': Routine exposure to AI may reduce ADR in standard colonoscopy
References:
Budzyń K, et al. Lancet Gastroenterol Hepatol. 2025;doi:10.1016/S2468-1253 (25) 00133-5.
Narula N, et al. Am J Gastro. 2025;doi:10.14309/ajg.0000000000003700.
Prasad S, et al. JAMA Netw Open. 2025;doi:10.1001/jamanetworkopen.2025.29746.
Seika P, et al. Clin Gastroenterol Hepatol. 2025;doi:10.1016/j.cgh.2025.08.015.
Stockdale AJ, et al. Lancet Gastroenterol Hepatol. 2025;doi:10.1016/S2468-1253(25)00163-3.
